JUAN
SANCHIS FORES
CATEDRÁTICO/A DE UNIVERSIDAD
Complejo Hospitalario de Toledo
Toledo, EspañaPublications en collaboration avec des chercheurs de Complejo Hospitalario de Toledo (17)
2023
-
Age-Related Effects of COVID-19 Pandemic on Mechanical Reperfusion and 30-Day Mortality for STEMI: Results of the ISACS-STEMI COVID-19 Registry
Journal of Clinical Medicine, Vol. 12, Núm. 6
-
Gender Difference in the Effects of COVID-19 Pandemic on Mechanical Reperfusion and 30-Day Mortality for STEMI: Results of the ISACS-STEMI COVID-19 Registry
Journal of Clinical Medicine, Vol. 12, Núm. 3
-
SARS-CoV-2 Positivity, Stent Thrombosis, and 30-day Mortality in STEMI Patients Undergoing Mechanical Reperfusion
Angiology, Vol. 74, Núm. 10, pp. 987-996
2022
-
Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: The SUGAR trial
European Heart Journal, Vol. 43, Núm. 13, pp. 1320-1330
-
COVID-19 pandemic, mechanical reperfusion and 30-day mortality in ST elevation myocardial infarction
Heart (British Cardiac Society), Vol. 108, Núm. 6, pp. 458-466
-
Impact of Smoking Status on Mortality in STEMI Patients Undergoing Mechanical Reperfusion for STEMI: Insights from the ISACS–STEMI COVID-19 Registry
Journal of Clinical Medicine, Vol. 11, Núm. 22
-
Impact of chronic obstructive pulmonary disease on short-term outcome in patients with ST-elevation myocardial infarction during COVID-19 pandemic: insights from the international multicenter ISACS-STEMI registry
Respiratory Research, Vol. 23, Núm. 1
2021
-
Comparison of One-Year Outcomes Between the ihtDEStiny BD Stent and the Durable-Polymer Everolimus- and Zotarolimus-Eluting Stents: A Propensity-Score-Matched Analysis
Cardiovascular Revascularization Medicine, Vol. 31, pp. 1-6
-
Impact of renin-angiotensin system inhibitors on mortality during the COVID Pandemic among STEMI patients undergoing mechanical reperfusion: Insight from an international STEMI registry
Biomedicine and Pharmacotherapy, Vol. 138
2020
-
Benefit of primary percutaneous coronary interventions in the elderly with ST segment elevation myocardial infarction
Open Heart, Vol. 7, Núm. 2
-
Impact of COVID-19 pandemic and diabetes on mechanical reperfusion in patients with STEMI: insights from the ISACS STEMI COVID 19 Registry
Cardiovascular Diabetology, Vol. 19, Núm. 1
2019
-
Baseline Risk Stratification of Patients Older Than 75 Years With Infarction and Cardiogenic Shock Undergoing Primary Angioplasty
Revista Espanola de Cardiologia, Vol. 72, Núm. 12, pp. 1005-1011
2018
-
Multivessel disease in patients over 75 years old with ST elevated myocardial infarction. Current management strategies and related clinical outcomes in the ESTROFA MI + 75 nation-wide registry
Cardiovascular Revascularization Medicine, Vol. 19, Núm. 5, pp. 580-588
2017
-
Angioplastia primaria en mayores de 75 años. Perfil de pacientes y procedimientos, resultados y predictores pronósticos en el registro ESTROFA IM + 75
Revista Espanola de Cardiologia, Vol. 70, Núm. 2, pp. 81-87
-
Usefulness of Drug-Eluting Balloons for Bare-Metal and Drug-Eluting In-Stent Restenosis (from the RIBS IV and V Randomized Trials)
American Journal of Cardiology, Vol. 119, Núm. 7, pp. 983-990
2016
-
Long-Term Results of Everolimus-Eluting Stents Versus Drug-Eluting Balloons in Patients With Bare-Metal In-Stent Restenosis: 3-Year Follow-Up of the RIBS V Clinical Trial
JACC: Cardiovascular Interventions, Vol. 9, Núm. 12, pp. 1246-1255
2014
-
A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: The RIBS v clinical trial (restenosis intra-stent of bare metal stents: Paclitaxel-eluting balloon vs. everolimus-eluting stent)
Journal of the American College of Cardiology, Vol. 63, Núm. 14, pp. 1378-1386